Synnovation Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.synnovationtx.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)SNV4818 in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Pikavation Therapeutics, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06736704
- Locations
- 🇺🇸
Thomas Jefferson University-Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
🇦🇺Monash Health, Clayton, Victoria, Australia
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
SNV1521 in Participants with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Synnovation Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06220864
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇦🇺Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
News
No news found